159 related articles for article (PubMed ID: 31400751)
1. Up-regulation of SPC25 promotes breast cancer.
Wang Q; Zhu Y; Li Z; Bu Q; Sun T; Wang H; Sun H; Cao X
Aging (Albany NY); 2019 Aug; 11(15):5689-5704. PubMed ID: 31400751
[TBL] [Abstract][Full Text] [Related]
2. SPC25 overexpression promotes tumor proliferation and is prognostic of poor survival in hepatocellular carcinoma.
Zhang B; Zhou Q; Xie Q; Lin X; Miao W; Wei Z; Zheng T; Pang Z; Liu H; Chen X
Aging (Albany NY); 2020 Dec; 13(2):2803-2821. PubMed ID: 33408271
[TBL] [Abstract][Full Text] [Related]
3. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
Chen J; Chen H; Yang H; Dai H
Biomed Pharmacother; 2018 Apr; 100():233-239. PubMed ID: 29432994
[TBL] [Abstract][Full Text] [Related]
4. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract][Full Text] [Related]
5. TP73-AS1 promotes breast cancer cell proliferation through miR-200a-mediated TFAM inhibition.
Yao J; Xu F; Zhang D; Yi W; Chen X; Chen G; Zhou E
J Cell Biochem; 2018 Jan; 119(1):680-690. PubMed ID: 28639399
[TBL] [Abstract][Full Text] [Related]
6. Spindle pole body component 25 regulates stemness of prostate cancer cells.
Cui F; Tang H; Tan J; Hu J
Aging (Albany NY); 2018 Nov; 10(11):3273-3282. PubMed ID: 30408771
[TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_001569 is an unfavorable prognostic factor and promotes cell proliferation and metastasis by modulating PI3K-AKT pathway in breast cancer.
Xu JH; Wang Y; Xu D
Cancer Biomark; 2019; 25(2):193-201. PubMed ID: 31104012
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of Circular RNA circ_0005230 Indicates Dismal Prognosis in Breast Cancer and Regulates Cell Proliferation and Invasion via miR-618/ CBX8 Signal Pathway.
Xu Y; Yao Y; Leng K; Ji D; Qu L; Liu Y; Cui Y
Cell Physiol Biochem; 2018; 51(4):1710-1722. PubMed ID: 30504704
[TBL] [Abstract][Full Text] [Related]
9. miR‑425‑5p is associated with poor prognosis in patients with breast cancer and promotes cancer cell progression by targeting PTEN.
Xiao S; Zhu H; Luo J; Wu Z; Xie M
Oncol Rep; 2019 Dec; 42(6):2550-2560. PubMed ID: 31638259
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of CKS2 is associated with a poor prognosis and promotes cell proliferation and invasion in breast cancer.
Huang N; Wu Z; Hong H; Wang X; Yang F; Li H
Mol Med Rep; 2019 Jun; 19(6):4761-4769. PubMed ID: 30957190
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of Derlin 3 is associated with malignant phenotype of breast cancer cells.
Shibata M; Kanda M; Tanaka H; Umeda S; Miwa T; Shimizu D; Hayashi M; Inaishi T; Miyajima N; Adachi Y; Takano Y; Nakanishi K; Takeuchi D; Noda S; Kodera Y; Kikumori T
Oncol Rep; 2017 Sep; 38(3):1760-1766. PubMed ID: 28713959
[TBL] [Abstract][Full Text] [Related]
13. Down-regulated expression of LINC00518 prevents epithelial cell growth and metastasis in breast cancer through the inhibition of CDX2 methylation and the Wnt signaling pathway.
Wang HB; Wei H; Wang JS; Li L; Chen AY; Li ZG
Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):708-723. PubMed ID: 30611858
[TBL] [Abstract][Full Text] [Related]
14. MiRNA-106a promotes breast cancer progression by regulating DAX-1.
Liu C; Song YH; Mao Y; Wang HB; Nie G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1574-1583. PubMed ID: 30840280
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of hsa_circ_0007534 suppresses breast cancer cell proliferation and invasion by targeting miR-593/MUC19 signal pathway.
Song L; Xiao Y
Biochem Biophys Res Commun; 2018 Sep; 503(4):2603-2610. PubMed ID: 30139516
[TBL] [Abstract][Full Text] [Related]
16. CircIRAK3 sponges miR-3607 to facilitate breast cancer metastasis.
Wu J; Jiang Z; Chen C; Hu Q; Fu Z; Chen J; Wang Z; Wang Q; Li A; Marks JR; Guo C; Chen Y; Zhou J; Yang L; Lin C; Wang S
Cancer Lett; 2018 Aug; 430():179-192. PubMed ID: 29803789
[TBL] [Abstract][Full Text] [Related]
17. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
18. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
[TBL] [Abstract][Full Text] [Related]
19. MiR-182-5p Knockdown Targeting PTEN Inhibits Cell Proliferation and Invasion of Breast Cancer Cells.
Zhao YS; Yang WC; Xin HW; Han JX; Ma SG
Yonsei Med J; 2019 Feb; 60(2):148-157. PubMed ID: 30666836
[TBL] [Abstract][Full Text] [Related]
20. Identification of novel biomarkers associated with poor patient outcomes in invasive breast carcinoma.
Canevari RA; Marchi FA; Domingues MA; de Andrade VP; Caldeira JR; Verjovski-Almeida S; Rogatto SR; Reis EM
Tumour Biol; 2016 Oct; 37(10):13855-13870. PubMed ID: 27485113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
